Skip to content
Menu

Celularity Regains Nasdaq Compliance

Benzinga Newsdesk 4 weeks ago

News

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced that it received written confirmation from the Listing Qualifications Staff of The

Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced that it received written confirmation from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") that Celularity has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the U.S. Securities and Exchange Commission.

Read at benzinga.com